Robbie McLaren

Partner

London
robbie.mclaren@lw.com
+44.20.7710.1880

PRACTICES

  • Emerging Companies & Growth
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation

INDUSTRIES

  • Artificial Intelligence
  • Healthcare & Life Sciences
  • Technology

BAR QUALIFICATIONS

  • England and Wales (Solicitor)
  • Scotland (Solicitor)

EDUCATION

  • Diploma in Legal Practice, University of Edinburgh, 2004
  • LLB (Hons), University of Edinburgh, 2003

LANGUAGES SPOKEN

  • English

PROFILE

Robbie McLaren, Global Vice Chair of the firm’s Healthcare & Life Sciences Industry Group, advises healthcare, technology, and life sciences companies across the full corporate life cycle.

Robbie leverages extensive experience on all sides of a transaction to represent market innovators in:

  • Cross-border mergers and acquisitions
  • Private equity
  • Joint ventures
  • Equity fundraisings
  • Public company representation
  • Carve-outs
  • Asset swaps 

A recognized leader within the firm, he previously served as Co-Chair of the London Corporate Department.

EXPERIENCE

Robbie’s representative clients include:

Life Sciences and Healthcare Companies

  • Abcam
  • GlaxoSmithKline
  • Watson Pharmaceuticals / Actavis / Allergan
  • SOBI
  • BenevolentAI
  • BBI Healthcare
  • Norgine
  • Atnahs Pharma (now Pharmanovia)
  • Immedica
  • Pharmathen
  • Theramex
  • Synthon
  • Osler Diagnostics
  • Zogenix

Private Equity (Healthcare and Life Sciences)

  • Novo Holdings 
  • BC Partners 
  • Nordic Capital 
  • TPG 
  • Patient Square Capital
  • The Carlyle Group
  • CVC
  • Impilo

Venture Investors

  • Novo Holdings
  • Andera 
  • Burda
  • Coatue

Technology Companies

  • Bloom & Wild 
  • Vertical Aerospace 
  • Moneybox
  • Darktrace
  • Carbon Clean 
  • Plastic Energy
  • Rivulis
  • Canva
  • Mimecast 
  • Netflix 
  • Intapp